GlassScriptPhysician profile
Michelle M Eynon
NPI 1427294552
$1,453.24
in general payments reported to CMS, 2019-2025
16 companies · $377 in 2025
The $377 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $455 · 2022: $16.99 · 2023: $311 · 2024: $293 · 2025: $377.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $981.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $980.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $237.60 | 2023-2024 | Rexulti |
| Myovant Sciences INC. | $178.13 | 2021-2022 | |
| Abbvie INC. | $174.19 | 2021-2023 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $127.39 | 2025 | Caplyta |
| Kyowa Kirin, INC. | $124.94 | 2025 | |
| Novo Nordisk INC | $124.89 | 2025 | Wegovy |
| Sage Therapeutics, LLC | $106.50 | 2023 | |
| Dexcom, INC. | $89.97 | 2024 | Dexcom G7 Gss (161) |
| Supernus Pharmaceuticals, INC. | $82.30 | 2024 | Qelbree |
| Exeltis, USA INC. | $55.80 | 2021 | |
| Therapeuticsmd, INC. | $43.14 | 2021 | |
| Merck Sharp & Dohme LLC | $30.39 | 2021 | |
| Sunovion Pharmaceuticals INC. | $27.88 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.81 | 2021 | |
| Evofem Biosciences, INC. | $15.25 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $13.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Eynon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.